Melanocortin peptides: MT-2 and PT-141 in research

What melanocortin peptides are

Melanocortin peptides form a class of synthetic compounds derived from the melanocortin system, a group of endogenous signalling molecules that act on melanocortin receptors. These receptors belong to the G protein coupled receptor family and are studied in research models for their role in various physiological signalling pathways. In laboratory research, synthetic analogues of these peptides are used to investigate receptor binding, signal transduction and downstream cellular processes.

MC1R and MC4R at the molecular level

Two receptor subtypes are central to research on this peptide class, MC1R and MC4R. MC1R is a receptor expressed in, among other tissues, melanocytes, and in research models it is linked to intracellular cAMP signalling. MC4R is a receptor subtype expressed predominantly in the central nervous system of animal models and is studied within the context of neuroendocrine signalling pathways. Research on these receptors focuses on binding affinity, receptor activation and the molecular cascades that follow.

MT-2 as a model compound

MT-2 (melanotan II) is a synthetic peptide studied in laboratory research as a non-selective agonist of melanocortin receptors, with affinity for both MC1R and MC4R. As a model compound, MT-2 is used to characterise receptor agonism within the melanocortin signalling pathway, for example in cell culture models and preclinical animal models mapping receptor expression and signal transduction.

PT-141 (bremelanotide) as a model compound

PT-141, also referred to as bremelanotide, is a synthetic peptide analogue structurally derived from melanocortin peptides that is studied primarily as a selective model compound for MC4R activation. In preclinical research models, PT-141 is used to dissect the molecular pathway of MC4R signalling, distinct from MC1R mediated processes. This makes the compound relevant to researchers seeking to distinguish receptor selectivity within the melanocortin family.

Research context

Both peptides are described exclusively within the context of laboratory and preclinical research into the melanocortin signalling pathway, receptor pharmacology and molecular biology. The information above concerns research models and is not intended as a description of use in humans.

• Molecular class: melanocortin receptor agonists
• Relevant receptors: MC1R, MC4R
• Model compounds: MT-2, PT-141 (bremelanotide)
• Research domain: receptor pharmacology, signal transduction